Innogenetics
Technologiepark 6
Gent
9052
Tel: 0032-9-329-16-40
Fax: 0032-9-329-19-08
Website: http://www.innogenetics.com/
Email: info@innogenetics.com
14 articles about Innogenetics
-
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
11/2/2010
-
Solvay Pharmaceuticals, Inc. Raises Innogenetics Bid, Beats off Gen-Probe Incorporated
7/9/2008
-
Innogenetics Shares Suspended on Euronext Brussels
7/9/2008
-
Gen-Probe Incorporated Does Not Intend to Increase Offer to Acquire Innogenetics
7/9/2008
-
Innogenetics Grants Cervical Cancer Licence to GlaxoSmithKline
7/2/2008
-
Gen-Probe Incorporated Launches Conditional Tender Offer For Innogenetics For US $334 Million
6/3/2008
-
Solvay SA Says to Pay 177.6M Euros for Innogenetics
4/25/2008
-
U.S. Court of Appeals Reinstates Permanent Injunction Against Abbott Laboratories for Infringing Innogenetics' Patent
3/9/2007
-
Court Permanently Halts Abbott Laboratories's Sale Of HCV Genotyping Products For Infringing Innogenetics' Patent
1/11/2007
-
Court Affirms $7 Million In Damages for Innogenetics In Patent Infringement Suit
1/4/2007
-
Innogenetics Release: Jury Finds Abbott Laboratories Willfully Infringed Innogenetics HCV Patent
9/11/2006
-
Innogenetics, Third Wave Technologies, Inc. Resolve Patent Suit
2/10/2006
-
Innogenetics And Abbott Laboratories End Distribution Deal
12/2/2005
-
Fibrosis Improved With hepatitis C Vaccine, Innogenetics Reports
3/25/2004